Background
Methods
Study design and participants
Instrument development
-
Revised observation period from “last three months of life” to “last year of life”.
-
Added questions about the communication of the diagnosis of a life-limiting disease to assess if, by whom, when and how conversations about dying were initiated.
-
Added the scale “subjective experiences of process and outcome of care in the last year of life” which comprises four key domains (relief of pain, relief of other symptoms, coordination of care, respect and dignity) in all settings of care.
-
Revised terminology to align with German sample.
-
Added sections related to healthcare providers additional available in the German healthcare system.
-
Added single items about informal carers, place of care in the last two days of life, unsolved problems, financial problems, and demographic and clinical data.
-
Harmonised response options and added “do not know” where appropriate.
Other instruments administered
Data collection
Data analysis
Validity
Reliability
Results
Characteristics of the sample
n | (%) | |
---|---|---|
Deceased age at death (years) | ||
18–29 | 1 | (0.3) |
30–49 | 6 | (1.7) |
50–64 | 65 | (18.5) |
65–79 | 112 | (31.9) |
80+ | 167 | (47.6) |
Deceased gender | ||
Female | 183 | (52.1) |
Male | 168 | (47.9) |
Deceased ethnic group | ||
German | 340 | (96.9) |
Other | 11 | (3.1) |
Deceased illnesses in the last year of lifea | ||
Cancer | 209 | (59.5) |
Cardiovascular disease | 142 | (40.5) |
Neuro-psychological disease | 115 | (32.8) |
Disease of the respiratory system | 103 | (29.3) |
Kidney disease | 52 | (14.8) |
Diabetes mellitus | 45 | (12.8) |
Liver disease | 15 | (4.3) |
Settings/Providers of careb | ||
Stayed in hospital (n = 350)c | 320 | (91.4) |
General practitioner (n = 349)c | 305 | (87.4) |
Outpatient specialist physician (n = 350)c | 270 | (77.1) |
Homecare: nursing service (n = 348)c | 157 | (45.1) |
Homecare: specialist palliative home care team (n = 348)c | 135 | (38.8) |
Stayed in care home (n = 335)c | 75 | (22.4) |
Stayed in hospice (n = 340)c | 64 | (18.8) |
Homecare: hospice volunteers (n = 348)c | 23 | (6.6) |
Place of death | ||
Hospital | 148 | (42.2) |
At home | 97 | (27.6) |
Hospice | 61 | (17.4) |
Care home | 41 | (11.7) |
Somewhere else | 4 | (1.1) |
Informant relation to deceased | ||
Spouse | 149 | (42.5) |
Son/daughter | 138 | (39.3) |
Other relative | 44 | (12.5) |
Friend | 12 | (3.4) |
Other | 8 | (2.3) |
Informant age (years) | ||
18–29 | 2 | (0.6) |
30–49 | 46 | (13.1) |
50–64 | 154 | (43.9) |
65–79 | 118 | (33.6) |
80+ | 31 | (8.8) |
Informant gender | ||
Female | 251 | (71.5) |
Male | 100 | (28.5) |
Validity
Construct validity
Hospice (in-patient) | Homecare | Hospital care (last admission) | Hospice vs. Homecare | Hospice vs. Hospital | ||||
---|---|---|---|---|---|---|---|---|
Domains
| n | Mean (SD) | n | Mean (SD) | n | Mean (SD) | p-value | p-value |
Relief of paina | 60 | 1.23 (0.50) | 246 | 1.76 (0.84) | 188 | 1.75 (0.80) | 0.035 | < 0.001 |
Relief of other symptomsa | 58 | 1.41 (0.68) | 255 | 2.00 (0.89) | 180 | 1.95 (0.83) | 0.001 | 0.010 |
Coordination of carea | 50 | 1.18 (0.63) | 244 | 1.73 (0.89) | 133 | 2.63 (1.18) | 0.001 | 0.006 |
Respect and dignityb | 64 | 1.09 (0.34) | 320 | 1.25 (0.41) | 201 | 1.74 (0.76) | 0.001 | < 0.001 |
‘Overall, and taking all services into account, how would you rate his/her care in the last year of life?’ | |||||||||
---|---|---|---|---|---|---|---|---|---|
Place of death
|
Good
|
Rather good
|
Rather bad
|
Bad
| |||||
n | (%) | n | (%) | n | (%) | n | (%) | Mean (SD) | |
Hospital (n = 65) | 16 | (24.6) | 32 | (49.2) | 13 | (20) | 4 | (6.2) | 2.08 (0.84) |
Non-hospital (n = 265) | 122 | (46) | 129 | (48.7) | 11 | (4.2) | 3 | (1.1) | 1.6 (0.63) |
Place of death | |||||
---|---|---|---|---|---|
Home (n = 97) | Non-home (n = 248) | ||||
n | (%) | n | (%) | ||
Patient received care from a specialist palliative home care team
| Yes (n = 135) | 67 | 49.6 | 68 | 50.4 |
No (n = 210) | 30 | 14.3 | 180 | 85.7 |
Patient received specialist palliative carea | |||
---|---|---|---|
Yes (n = 213) | No (n = 107) | ||
Indication
| Cancer (n = 200) | 172 (86%) | 28 (14%) |
Non-cancer (n = 120) | 41 (34.2%) | 79 (65.9%) |